Please use this identifier to cite or link to this item:
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Industrial and Systems Engineering-
dc.creatorHuang, J-
dc.creatorXu, Z-
dc.creatorjiang, Y-
dc.creatorLaw, WC-
dc.creatorDong, B-
dc.creatorZeng, X-
dc.creatorMa, M-
dc.creatorXu, G-
dc.creatorZou, J-
dc.creatorYang, C-
dc.publisherBioMed Central Ltd.en_US
dc.rights© The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativeco The Creative Commons Public Domain Dedication waiver ( zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.en_US
dc.rightsThe following publication Huang, J., Xu, Z., jiang, Y. et al. Metal organic framework-coated gold nanorod as an on-demand drug delivery platform for chemo-photothermal cancer therapy. J Nanobiotechnol 19, 219 (2021) is available at
dc.subjectDrug deliveryen_US
dc.subjectGold nanoroden_US
dc.subjectMetal organic frameworken_US
dc.subjectPhotothermal therapyen_US
dc.titleMetal organic framework-coated gold nanorod as an on-demand drug delivery platform for chemo-photothermal cancer therapyen_US
dc.typeJournal/Magazine Articleen_US
dcterms.abstractChemo-photothermal therapy based on nanoparticles has emerged as a promising strategy for cancer treatment. However, its therapeutic efficacy and application potential are largely subjected to the uncontrollability and biotoxicity of functional nanoplatforms. Herein, a novel biocompatible and biodegradable metal organic framework (MOF), which was constructed by growing crystalline zeolitic imidazolate framework-8 on gold nanoroad (Au@ZIF-8), was designed and fabricated for efficient drug loading and controlled release. Owing to the large surface area and guest-matching pore size of ZIF-8, doxorubicin (DOX) was successfully loaded into the Au@ZIF-8 with a high drug loading efficiency of ~ 37%. Under NIR light or weakly acidic environment, the ZIF-8 layer was quickly degraded, which resulted in an on-demand drug release in tumour site. More importantly, under the irradiation of near infrared (NIR) laser, highly efficient cancer treatment was achieved in both in vitro cell experiment and in vivo tumour-bearing nude mice experiment due to the synergistic effect of photothermal (PTT) therapy and chemotherapy. In addition, the in vivo study revealed the good biocompatibility of Au@ZIF-8. This work robustly suggested that Au@ZIF-8 could be further explored as a drug delivery system for chemo-photothermal synergistic therapy.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationJournal of nanobiotechnology, 2021, v. 19, 219-
dcterms.isPartOfJournal of nanobiotechnology-
dc.description.validate202110 bcvc-
dc.description.oaVersion of Recorden_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
Huang2021_Article_MetalOrganicFramework-coatedGo.pdf4 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

Citations as of Jun 19, 2022


Citations as of Jun 23, 2022


Citations as of Jun 23, 2022

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.